This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a client with an IV line continuously infusing solution containing dextrose ... (Read 94 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
The nurse is caring for a client with an IV line continuously infusing solution containing dextrose and water.
 
  The client complains of a burning pain along the course of the vein, and the nurse assesses the site to find redness, warmth, and mild swelling at the site. Based on these assessment findings, which term will the nurse use when documenting these findings?
  1. Phlebitis at the IV insertion site
  2. IV infiltrate
  3. Extravasated vesicant drug
  4. Extravasation

Question 2

The nurse is initiating IV therapy for an adult client who requires IV fluid infusion for 2-3 days and might require blood administration.
 
  Which would the nurse choose as the best option for IV catheterization?
  1. Butterfly
  2. Huber needle
  3. Angiocatheter
  4. Implantable venous access device



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

elyse44

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Correct Answer: 1

Redness, warmth, edema, and pain that runs along the course of the vein characterize phlebitis. Dextrose and water are not vesicants, and do not require immediate intervention. An infiltrate is defined as fluid entering the tissues, resulting in swelling, coolness, pallor, and discomfort at the site. This client's site is red and warm, not cool and pale, so it is not an infiltrate. Extravasation includes a vesicant drug (one that causes blistering when in the tissues but not in the vascular system), so this is not an extravasation.

Answer to Question 2

Correct Answer: 3

An angiocatheter would be the best choice because the needle is removed and only the catheter remains in place, so it is more likely to last for 2 days without infiltrating. A butterfly can be used, if necessary, for IV catheterization, but is best when used for short-term IV infusion, as the needle remains in place within the vein, and is more likely to infiltrate sooner than is an angiocatheter. A Huber needle is used to access an implantable venous access device, and would not be used for short-term use of a few days. Implantable venous access devices are used when IV fluid needs are anticipated for several months.





 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

For a complete list of videos, visit our video library